The news that the top U.S. health agency is recommending rescheduling marijuana is earning applause from congressional lawmakers across the aisle, including longstanding bipartisan champions of reform like Sen. John Fetterman (D-PA) and Rep. Dave Joyce (R-OH), who are claiming partial credit for the development.
Numerous lawmakers have responded with enthusiasm after it was reported on Wednesday that the U.S. Department of Health and Human Services (HHS) advised the Drug Enforcement Administration (DEA) that it believes cannabis should be moved from Schedule I to Schedule III under the Controlled Substances Act (CSA) following a scientific review directed by the president last year.
Those responses continue to pour in, with advocates and industry stakeholders now contemplating the broader implications of rescheduling. And some legislators want a piece of the credit for their years of advocacy.
“For many, many years now, I have been pushing for decisive action on marijuana,” Fetterman said in a statement on Thursday. “Nearly one year ago to the day, I met with President Biden in Pittsburgh and requested that he and his administration do something on marijuana policy.”
Yesterday’s move is a massive win for the Biden administration and a strong step in the right direction
Read full article on Marijuana Moment
